These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1913980)

  • 1. Oral glutathione increases tissue glutathione in vivo.
    Aw TY; Wierzbicka G; Jones DP
    Chem Biol Interact; 1991; 80(1):89-97. PubMed ID: 1913980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of dietary glutathione: effect on plasma concentration.
    Hagen TM; Wierzbicka GT; Sillau AH; Bowman BB; Jones DP
    Am J Physiol; 1990 Oct; 259(4 Pt 1):G524-9. PubMed ID: 2221062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
    Lee FY; Allalunis-Turner MJ; Siemann DW
    Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glutathione synthesis of Ascaris suum by buthionine sulfoximine.
    Hussein AS; Walter RD
    Parasitol Res; 1996; 82(4):372-4. PubMed ID: 8740556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of brain glutathione in preweanling mice by L-buthionine sulfoximine.
    Slivka A; Spina MB; Calvin HI; Cohen G
    J Neurochem; 1988 May; 50(5):1391-3. PubMed ID: 3361302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
    Gallagher EP; Hasspieler BM; Di Giulio RT
    Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
    Hum S; Robitaille L; Hoffer LJ
    Can J Physiol Pharmacol; 1991 May; 69(5):581-7. PubMed ID: 1863907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation.
    Leeuwenburgh C; Ji LL
    Arch Biochem Biophys; 1995 Feb; 316(2):941-9. PubMed ID: 7864653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of glutathione synthesis on the immunogenicity of captopril and captopril-protein conjugates in the mouse.
    Yeung JH
    Biochem Pharmacol; 1990 Sep; 40(6):1235-40. PubMed ID: 2206138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buthionine sulfoximine (BSO) on mercury distribution after Hg(o) exposure.
    Kim CY; Watanabe C; Satoh H
    Toxicology; 1995 Apr; 98(1-3):67-72. PubMed ID: 7740555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione oxidation and embryotoxicity elicited by diamide in the developing rat conceptus in vitro.
    Hiranruengchok R; Harris C
    Toxicol Appl Pharmacol; 1993 May; 120(1):62-71. PubMed ID: 8511783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.
    Pileblad E; Magnusson T
    J Neurochem; 1989 Dec; 53(6):1878-82. PubMed ID: 2809598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.